Article

CIMAvax comes to U.S. after years of development in Cuba

Publish date: May 11, 2016

 

References

jcraig@frontlinemedcom.com

On Twitter @jess_craig94

Pages

Recommended Reading

Immune-related events with checkpoint inhibitors are manageable
MDedge Internal Medicine
Hold the checkpoint inhibitors when pneumonitis symptoms occur
MDedge Internal Medicine
Former smokers turning to e-cigarettes
MDedge Internal Medicine
Late risks of breast cancer RT are higher for smokers
MDedge Internal Medicine
Families perceive few benefits from aggressive end-of-life care
MDedge Internal Medicine
Deciphering lung cancer biomarkers shrouded in tobacco smoke
MDedge Internal Medicine
Research refining radiomic features for lung cancer screening
MDedge Internal Medicine
Study evaluates which prior cancers pose a risk for developing NSCLC
MDedge Internal Medicine
Quitting smoking plus low-dose helical CT reduces lung cancer death risk
MDedge Internal Medicine
Does sharing genetic risk change behavior?
MDedge Internal Medicine